Literature DB >> 26141260

Dysphagia in head and neck cancer patients treated with radiotherapy and systemic therapies: Literature review and consensus.

Antonio Schindler1, Nerina Denaro2, Elvio G Russi3, Nicole Pizzorni4, Paolo Bossi5, Anna Merlotti6, Massimo Spadola Bissetti7, Gianmauro Numico8, Alessandro Gava9, Ester Orlandi10, Orietta Caspiani11, Michela Buglione12, Daniela Alterio13, Almalina Bacigalupo14, Vitaliana De Sanctis15, Giovanni Pavanato16, Carla Ripamonti17, Marco C Merlano18, Lisa Licitra19, Giuseppe Sanguineti20, Johannes A Langendijk21, Barbara Murphy22.   

Abstract

BACKGROUND: Head and neck cancer (HNC) and its therapy are associated with acute and late swallowing dysfunction. Consensus guidelines regarding evaluation and management are lacking. To address this gap, a multidisciplinary team of experts (oncologists, practitioners, deglutologists, etc.) met in Milan 17-18 February 2013 with the aim of reaching a consensus on the management of swallowing difficulties in HNC patients treated with radiotherapy with or without systemic therapies (such as chemotherapy and targeted agents). The consensus was focused particularly on those statements with limited evidence. The results of the literature review and the statements that obtained a consensus are reported and discussed in this paper.
MATERIALS AND METHODS: The Delphi Appropriateness Method was used for this consensus. External expert reviewers then evaluated the conclusions carefully according to their area of expertise.
RESULTS: This paper contains 6 clusters of statements about the management of swallowing problems in radio-treated HNC patients and a review of the recent literature on these topics.
CONCLUSIONS: Dysphagia assessment and its management are difficult and require a multi-team cooperation (ENT specialists, radiation and medical oncologists, deglutologists, etc.).
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Chemotherapy; Deglutition; Dysphagia; Head and neck cancer; Radiation oncology; Radiotherapy; Swallowing dysfunction

Mesh:

Year:  2015        PMID: 26141260     DOI: 10.1016/j.critrevonc.2015.06.005

Source DB:  PubMed          Journal:  Crit Rev Oncol Hematol        ISSN: 1040-8428            Impact factor:   6.312


  32 in total

1.  Optimising Radiation Therapy Dose to the Swallowing Organs at Risk: An In Silico Study of feasibility for Patients with Oropharyngeal Tumours.

Authors:  Molly K Barnhart; Bena Cartmill; Elizabeth C Ward; Elizabeth Brown; Jonathon Sim; George Saade; Sandra Rayner; Rachelle A Robinson; Virginia A Simms; Robert I Smee
Journal:  Dysphagia       Date:  2019-02-11       Impact factor: 3.438

Review 2.  A comparison of swallowing dysfunction after three-dimensional conformal and intensity-modulated radiotherapy : A systematic review by the Italian Head and Neck Radiotherapy Study Group.

Authors:  Stefano Ursino; Elisa D'Angelo; Rosario Mazzola; Anna Merlotti; Riccardo Morganti; Agostino Cristaudo; Fabiola Paiar; Daniela Musio; Daniela Alterio; Almalina Bacigalupo; Elvio Grazioso Russi; Frank Lohr
Journal:  Strahlenther Onkol       Date:  2017-06-14       Impact factor: 3.621

3.  Validation of the Chinese version of the Head and Neck Patient Symptom Checklist for measuring nutrition impact symptoms during radiotherapy in patients with head and neck cancer.

Authors:  Sanli Jin; Qian Lu; Dong Pang; Yan Sun; Shaowen Xiao; Baomin Zheng; Hangjing Cui
Journal:  Support Care Cancer       Date:  2019-04-04       Impact factor: 3.603

4.  Swallowing-related outcomes associated with late lower cranial neuropathy in long-term oropharyngeal cancer survivors: cross-sectional survey analysis.

Authors:  Puja Aggarwal; Jhankruti S Zaveri; Ryan P Goepfert; Qiuling Shi; Xianglin L Du; Michael Swartz; Stephen Y Lai; C David Fuller; Jan S Lewin; Linda B Piller; Katherine A Hutcheson
Journal:  Head Neck       Date:  2019-08-23       Impact factor: 3.147

5.  Predictors of Patient-Reported Dysphagia Following IMRT Plus Chemotherapy in Oropharyngeal Cancer.

Authors:  Ester Orlandi; Rosalba Miceli; Gabriele Infante; Aurora Mirabile; Daniela Alterio; Maria Cossu Rocca; Nerina Denaro; Riccardo Vigna-Taglianti; Annamaria Merlotti; Antonio Schindler; Nicole Pizzorni; Carlo Fallai; Lisa Licitra; Paolo Bossi
Journal:  Dysphagia       Date:  2018-06-08       Impact factor: 3.438

6.  Fentanyl pectin nasal spray for painful mucositis in head and neck cancers during intensity-modulated radiation therapy with or without chemotherapy.

Authors:  R Mazzola; F Ricchetti; A Fiorentino; N Giaj-Levra; S Fersino; U Tebano; S Albanese; S Gori; F Alongi
Journal:  Clin Transl Oncol       Date:  2016-11-16       Impact factor: 3.405

7.  Volumetric modulated arc therapy (VMAT) and simultaneous integrated boost in head-and-neck cancer: is there a place for critical swallowing structures dose sparing?

Authors:  Savino Cilla; Francesco Deodato; Gabriella Macchia; Cinzia Digesù; Anna Ianiro; Angelo Piermattei; Vincenzo Valentini; Alessio G Morganti
Journal:  Br J Radiol       Date:  2016-01-05       Impact factor: 3.039

8.  Neuromuscular function and fatigability in people diagnosed with head and neck cancer before versus after treatment.

Authors:  Colin Lavigne; Harold Lau; George Francis; S Nicole Culos-Reed; Guillaume Y Millet; Rosie Twomey
Journal:  Eur J Appl Physiol       Date:  2020-04-06       Impact factor: 3.078

9.  Pattern of dysphagia after swallowing-sparing intensity-modulated radiotherapy (IMRT) of head and neck cancers: results of a mono-institutional prospective study.

Authors:  Stefano Ursino; Paola Cocuzza; Veronica Seccia; Durim Delishaj; Agostino Cristaudo; Francesco Pasqualetti; Patrizia Giusti; Stefania Santopadre; Riccardo Morganti; Francesco Fiorica; Fabiola Paiar; Bruno Fattori
Journal:  Strahlenther Onkol       Date:  2018-07-09       Impact factor: 3.621

10.  Whiplash-Associated Dysphagia: Considerations of Potential Incidence and Mechanisms.

Authors:  D Stone; H Bogaardt; S D Linnstaedt; B Martin-Harris; A C Smith; D M Walton; E Ward; J M Elliott
Journal:  Dysphagia       Date:  2019-08-03       Impact factor: 3.438

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.